PALO ALTO, Calif., June 3 /PRNewswire/ -- PEAK Surgical, Inc., a medical device company that is developing a new tissue dissection system based on a proprietary technology, has appointed Terry E. Spraker, Ph.D., to the company's board of directors. Spraker most recently served as president, chief executive officer and director of Solarant Medical, Inc.
"Terry Spraker is a medical device industry veteran with more than 30 years of experience," said John Tighe, president and chief executive officer of PEAK Surgical. "His experience serving as a CEO and managing and growing medical device and equipment companies will be invaluable as we move our PEAK Surgery System through development and into commercialization."
The PEAK(R) Surgery System, PEAK's flagship product in development, combines the PULSAR(TM) Generator, which supplies pulsed plasma radiofrequency energy, with the PEAK PlasmaBlade(TM), a disposable cutting tool that offers the exacting control of a scalpel and the bleeding control of traditional electrosurgery without the extensive collateral damage. The PEAK Surgery System is not yet available in the United States. The company has filed a 510(k) pre-market notification with the U.S. Food and Drug Administration to market the system.
During his career, Spraker has served as CEO or president of two other companies in addition to Solarant Medical, a women's healthcare company. These include UroQuest Medical Corp., a publicly traded medical device company developing urology and airway management products, and EP Technologies, a medical device company that marketed radiofrequency therapies used in interventional cardiac electrophysiology. He joined EP Technologies when it was a small venture-funded start-up company, successfully managed and guided it through an initial public offering and secondary financing, and negotiated a merger with Boston Scientific.
Earlier in his career, he served as vice president/general manager of the global coronary business for Medtronic/AVE, a division of Medtronic, Inc. comprised of coronary, peripheral and endovascular business units. At Ohmeda, a medical equipment and pharmaceutical manufacturer of anesthesia and critical care products, he served in a variety of positions, most recently as president of the Medical Systems Division. Spraker's experience also includes serving as a venture partner with Aberdare Ventures, a venture fund focusing on biotech and medical devices. He currently serves on the board of directors of SpineWorks Medical, Inc.
Spraker received a bachelor's degree in electrical engineering from the University of Bridgeport as well as a master's degree in electrical engineering and a Ph.D. in bioengineering from Pennsylvania State University.
About PEAK Surgical, Inc.
PEAK Surgical, Inc. is a medical device company that is developing a new tissue dissection system based on a proprietary technology. PEAK's flagship product in development, the PEAK(R) Surgery System, combines the PULSAR(TM) Generator, which supplies pulsed plasma radiofrequency energy, with the PEAK PlasmaBlade(TM), a disposable cutting tool that offers the exacting control of a scalpel and the bleeding control of traditional electrosurgery without the extensive collateral damage. The company is exploring the applicability of this technology across numerous surgical fields, including general, cardiac, gynecologic, plastic and neurosurgery. For more information, please visit http://www.peaksurgical.com.
SOURCE PEAK Surgical, Inc.
